Committed to responsible pain management
Developing innovative and differentiated products for people suffering from pain
At Collegium Pharmaceutical we are committed to being the leader in responsible pain management. We have developed a portfolio of meaningfully differentiated products for use in the treatment of moderate to severe pain.
News and Press
Collegium Announces Publication of “Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza® ER” in Pain MedicineRead More October 26, 2020
Collegium to Host Conference Call to Discuss Third Quarter 2020 Financial Results and Provide Corporate UpdateRead More October 22, 2020